As we gear up for the 2016 election, we’re thinking critically about how the next US president can increase the impact and efficiency of America’s taxpayer-funded global health investments. The US lacks a government-wide strategy on global health engagement, and it shows—most recently in the slow and messy response to the Ebola crisis. But we think it doesn’t have to be this way.
Global Health Policy Blog
CGD experts blog on global health issues such as health financing, drug resistance, clinical trials, vaccine development, HIV/AIDS, and health-related foreign assistance.